>
pdufa.bio

KYV-101

Updated ยทnext FDA decision on the calendar

KYV-101 is a Kyverna Therapeutics, Inc. program. Its next catalyst is a Readout in Feb 2027. Every date links its source.

KYTX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Kyverna Therapeutics, Inc. (KYTX). We track 2 catalyst events for this program: 2 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Feb 2027KYTXReadout · Apr 2027KYTX

Questions

When is KYV-101's next FDA decision or readout?

The next tracked catalyst for KYV-101 is a Readout in Feb 2027.

What happened at KYV-101's most recent FDA decision?

No FDA decision for KYV-101 is in our archive yet.

Who makes KYV-101?

Kyverna Therapeutics, Inc. (KYTX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.